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ABSTRACT The precise catalytic strategies used for the breakdown of the complex bacterial 
polysaccharide xanthan, an increasingly frequent component of processed human foodstuffs, have 
remained a mystery. Here we present the characterization of an endo-xanthanase from 
Paenibacillus sp. 62047. We show that it is a CAZy family 9 glycoside hydrolase (GH9) 
responsible for the hydrolysis of the xanthan backbone, capable of generating tetrameric xanthan 
oligosaccharides from polysaccharide lyase family 8 (PL8) xanthan lyase-treated xanthan. 3-D 
structure determination reveals a complex multi-modular enzyme in which a catalytic (α/α)6 barrel 
is flanked by an N-terminal "immunoglobulin-like" (Ig-like) domain (frequently found in GH9 
enzymes) and by four additional C-terminal all β-sheet domains which have very few homologs 
in sequence databases and, at least, one of which functions as a new xanthan-binding domain, now 
termed CBM84. The solution phase conformation and dynamics of the enzyme in the native 
calcium-bound state and in the absence of calcium were probed experimentally by 
hydrogen/deuterium exchange mass spectrometry. Measured conformational dynamics were used 
to guide the protein engineering of enzyme variants with increased stability in the absence of 
calcium; a property of interest for the potential use of the enzyme in cleaning detergents. The 
ability of hydrogen/deuterium exchange mass spectrometry to pinpoint dynamic regions of a 
protein under stress (e.g. removal of calcium ions) makes this technology a strong tool for 
improving protein catalyst properties by informed engineering.  
KEYWORDS Enzyme, carbohydrate. Xanthan, Hydrogen/deuterium exchange mass 
spectrometry, enzyme stability, enzyme dynamics 
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INTRODUCTION 
Xanthan (Figure 1) is a complex, extracellular hetero-polysaccharide that is produced by bacterial 
strains from the genus Xanthomonas, pathovars of which (e.g. Xanthomonas campestris var. 
campestris) are also well-known as causative agents of disease in agriculturally important 
vegetables1-2. Considerable industrial interest in xanthan stems from its favorable rheology 
modifying properties in applications ranging from food production, petroleum extraction, and 
pharmaceutical formulation 1, 3. Indeed, recent estimates indicate that 86 kilotonnes of xanthan are 
produced by fermentation each year at a value of ca. US$ 400 M4. 
 
Figure 1 Ð The structure of xanthan and products following treatment with PL8 xanthan 
lyase and PspXan9. Xanthan lyase cleaves the side chain GlcA-β1→4-pyruvylated mannose 
glycosidic linkage from native ÒpolypentamericÓ xanthan (A), resulting in the formation of a Δ4,5-
ene-GlcA residue and release of pyruvylated mannose. The resulting ÒpolytetramericÓ xanthan (B) 
is the preferred substrate for the GH9 endo-xanthanase, which yields tetrasaccharides (C) as limit-
digest products. Acetylation is variable. 
 
Structurally, xanthan comprises a regular, pentasaccharide-based repeating structure based on a 
cellulose-like β(1→4)-glucan backbone (Figure 1)5. Alternating backbone residues bear a side 
chain consisting of an inner α(1→3)-mannosyl residue to which a β(1→2)-glucuronic acid residue 
and terminal β(1→4)-mannosyl residue are attached. This core carbohydrate structure is further 
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elaborated by the addition of a 6-O-acetyl group on the inner α-D-mannosyl residue and a pyruvyl 
group on the terminal β-D-mannose to create a 4,6-O-[(S)-1-carboxyethylidene] moiety. 
Acetylation and pyruvylation occurs on ca. 50% and 30%, respectively, of the pentasaccharide 
repeating units. The frequency of occurrence depends on the particular Xanthomonas strain and on 
fermentation conditions 6-8. 
In light of the notable effects of polysaccharide primary structure on application properties, there 
is considerable interest in the controlled modification of xanthan during biosynthesis 2 as well as 
through subsequent enzymatic processing. Our work is therefore focused on the discovery of novel 
active xanthanases. Furthermore, as the human genome does not encode xanthanases, there is 
interest in xanthanase discovery in the context of potential polysaccharide fiber degradation by the 
human microbiota. This aims to aid functional annotation of these organisms. Xanthan-degrading 
enzymes have been obtained from bacteria, including Bacillus sp., Corynebacterium sp. (for 
example ref.9), and a mixed culture10 capable of growth on the polysaccharide. Commensurate 
with the structural complexity of xanthan, complete saccharification involves sequential action of 
an extracellular xanthan lyase, an extracellular endo-β-glucanase, and three intracellular exo-
glycosidases: β-glucosidase, glucuronidase, and α-mannosidase9, 11-14. Recent whole-genome 
analysis indicates that some xanthan-utilizing bacteria, exemplified by Microbacterium sp. strain 
XT11, encode these enzymes and requisite sugar transporters via a single, transcriptionally co-
regulated gene cluster15. 
The first xanthan-degrading enzymes to be biochemically and structurally characterized in detail 
were the xanthan lyases (EC 4.2.2.12), which release pyruvylated mannose via eliminative 
cleavage with concomitant production of a Δ4,5-unsaturated glucuronic acid (Δ4,5-ene-GlcA) side 
chain (Figure 1)10. These enzymes were originally purified from a salt-tolerant mixed culture16, 
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from a Bacillus sp.17, and Paenibacillus alginolyticus6 and are now defined as members of 
Polysaccharide Lyase Family 8 (PL8) 18. The PL8 xanthan lyase from Bacillus sp. GL1 presently 
serves as the lone structural representative of these enzymes, including both substrate and product 
complexes 19-21. 
Xanthan backbone hydrolysis is mediated by specific endo-glucanases which generally require the 
prior action of xanthan lyase to allow attack on the β(1→4)-glucan chain (Figure 1)9-10, 12 (see 22 
for a notable exception). Recent analysis places bacterial endo-xanthanases as members of 
Glycoside Hydrolase Family 9 (GH9)15, a family more commonly associated with cellulase 
(unbranched endo-β(1→4)-glucanase) activity (EC 3.2.1.4)23. Currently, the nature of the 
structural determinants that confer xanthan specificity among selected GH9 members remains 
fundamentally unresolved.  
To address this issue, we describe here the substrate specificity, crystal structure, and 
conformational dynamics of PspXan9, a recently identified GH9 endo-xanthanase from 
Paenibacillus sp. 62047.24 Reflecting previous studies on xanthanases, PspXan9 is highly 
specific for lyase-treated xanthan, but is nonetheless weakly active on untreated native xanthan, 
other (β1→4)-glucans, and (β1→4)-xylans. The crystal structure strikingly revealed that 
PspXan9 has a hexamodular tertiary structure that is unique among GH9 members with four 
calcium-binding sites in the GH9 catalytic domain. The activity and thermostability of PspXan9 
were found to be highly dependent on the presence of calcium ions indicating an important role 
in stabilizing the protein fold. To assess the solution-phase conformational properties of native 
PspXan9 as well as the impact of calcium ion removal, we performed hydrogen/deuterium 
exchange mass spectrometry (HDX-MS) on the enzyme in the presence and absence of calcium 
ions. Differential deuterium uptake between the two states revealed increased dynamics / 
 6 
solvation of backbone amide hydrogens in the absence of calcium near the calcium ion 
environment detected in the crystal structure. Additionally, the absence of calcium resulted in 
large increases in dynamics of the β3 domain and in regions of the C-terminal domain that are 
disordered in the crystal structure. Remarkably, we found that calcium ion removal in three 
regions leads to the occurrence of distinct populations of PspXan9 with slow refolding kinetics 
in comparison to the native state, strongly indicating the presence of additional calcium binding 
sites in the C-terminal CBM84 domain. Finally, we used the dynamic information obtained by 
HDX-MS to guide rational engineering of PspXan9 variants with increased detergent stability. 
RESULTS AND DISCUSSION 
Enzyme cloning, expression and domain composition 
Several xanthan degrading bacterial strains were isolated from forest soil samples grown using 
xanthan gum as sole carbon source, similarly to Ref.9.  The gene encoding the PspXan9 was 
subsequently amplified by PCR from genomic DNA of the bacterium Paenibacillus sp. 62047, 
isolated from a forest soil sample collected in China and shown to have xanthanase activity.24 
Sequencing of 16S rRNA from this Paenibacillus species, revealed 99% identity to Paenibacillus 
nanensis (ARBSILVA:AB265206).  
The PspXan9 gene was cloned, expressed in Bacillus subtilis and purified as described in Materials 
and Methods. The gene sequence coding for PspXan9 was deposited in GenBank with accession 
No. MG661269. Sequence analysis, based on PSI-BLAST searches and examination of the CAZy 
database indicated the enzyme was made up of the following six domains (domain boundaries are 
approximate): 1-90: Ig-like (we term X229) domain present at the N-terminus of most GH9 
enzymes,    91-559: (α/α)6 catalytic module (GH9 in CAZy), 560-914: set of three β domains (β1; 
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560-657, β2; 658-814 and β3; 815-918) also found in a GH9 protein with accession code 
BAJ75824.1 [MTES_2860 Microbacterium testaceum StLB037; 43% sequence identity]. The 
PspXan9 sequence terminates with a domain, 915-1055, which shows low sequence similarity to 
a variety of CBMs, including CBM6.  
We were intrigued whether this C-terminal domain, which is also found on other Xanthan-active 
enzymes, might function as a novel xanthan-binding module. Xanthan-gum binding assays, 
Supporting Figure S1, indeed show a xanthan binding function and so this domain forms the root 
for a new CBM family termed CBM84. Preliminary experiments, in which this domain is removed, 
do not appear to reduce the activity of the PspXan9 enzyme on xanthan in the presence of xanthan 
lyase (data not shown).  
Notably, the PspXan9 catalytic domain sequence forms, with several others, a distinct sub-
group within GH9, characterized by much higher scores, better e-values, and a percentage of 
identity higher than approximately 50% with the query suggesting that it defines a sequence that 
can now be used for function prediction of related sequences. Close examples include previously 
"hypothetical proteins from Paenibacillus and Cohnella sp. (accession codes WP_079417835.1, 
WP_094047237.1, PRX68885.1, WP_082927563.1 all with over 62% sequence identity).!
!
Catalytic activity and specificity of recombinant PspXan9 
PspXan9 hydrolysis activity exhibited a strong dependence on the presence of Ca2+ ions in 
reactions at 37¡C in pH 7 HEPES-NaOH buffer (based on preliminary research on PspXan9 24). 
The maximum activity was obtained with 2 mM CaCl2, after which a monotonic decrease was 
observed (Figure S2a). In temperature optimization assays containing pH 7 HEPES-NaOH buffer 
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and 2 mM CaCl2, PspXan9 had the highest activity at 63¡C, but was also rapidly inactivated at 
temperatures immediately above this (Figure S2b). Therefore, the pH-rate profile was conducted 
at 55¡C to avoid any heat inactivation and resulted in data points forming an approximately bell-
shaped appearance, with the highest activity achieved at pH 7.0-7.5 in HEPES-NaOH buffer 
(Figure S2c). 
Further analysis revealed that thermostability during long-term incubations of the enzyme was, 
like activity, greatly improved in the presence of Ca2+. Specifically, incubation of diluted PspXan9 
in the absence of Ca2+ ions at temperatures between 45-69¡C led to a rapid decline in activity in 
all samples, with a 40% loss of activity at 45¡C after 1 h (Figure S2a,b). In contrast, incubation of 
the enzyme with 20 mM CaCl2 gave no detectable loss in activity over 1 h at temperatures up to 
60¡C, while at 54¡C PspXan9 retained > 75% activity after 48 h (Figure S3c,d). In consideration 
of these data, 55¡C was selected for subsequent kinetic analyses.  
PspXan9 demonstrated a clear preference for lyase treated xanthan compared to all other 
polysaccharides tested, including native, polypentameric xanthan, as displayed by a 630-fold 
greater specific activity (Table 1, cf. Figure 1). Paenibacillus sp are known to express xanthan 
lyaes, (including the strain used here25. Hydrolysis of the artificial (β1→4)-glucan derivatives 
carboxymethyl cellulose and hydroxyethyl cellulose, as well as cereal mixed linkage 
(β1→3)/(β1→4)-glucan, had similarly poor specific activities to native xanthan. Likewise, the 
highly branched (β1→4)-glucan, xyloglucan 26, and (β1→4)-xylans 27 were feebly hydrolyzed by 
PspXan9 (Table 1). Initial-rate kinetics of the hydrolysis of the dominant substrate, lyase-treated 
xanthan, were readily fit by the classic Michaelis-Menten equation (kcat = 1.69 x 104 min-1, Km = 
0.0962 mg!mL-1; Figure S4).	  
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Table	1. Kinetic analysis of the activity of PspXan9 on polysaccharide substrates. 
 Specific Activity  
Polysaccharide (U mg-1)* 
polypentameric xanthan (Figure 1) 0.285 ± 0.010 
lyase-treated xanthan (Figure 1) 181 ± 9 
CMC 0.492 ± 0.022 
HEC 0.180 ± 0.099 
bMLG 0.213 ± 0.029 
tXyG 0.0679 ± 0.0005 
bGX 0.0614 ± 0.0014 
wAX 0.0449 ± 0.0132 
*One enzyme unit (U) is defined as the amount of enzyme required to release 1 µmol of glucose 
reducing-end equivalents per minute. 
 
 
Structural Analysis of PspXan9 Products 
HPSEC-UV analysis of the degradation of lyase-treated xanthan by PspXan9 over time indicated 
that the enzyme acts processively, rapidly releasing short oligosaccharide products without 
releasing the polysaccharide chain (Figure 2a & S5). The polysaccharide (elution time 19.1 min, 
Figure S5a) was initially converted to produce a pair of partially resolved peaks eluting at 32.4 and 
33.2 min, the former of which was converted to the latter upon extended (9.5 h) incubation (Figure 
S5b-f). To identify the products giving rise to these two peaks, samples collected after 2 h and 9.5 
h of incubation (Figure 2a & S5e) were analyzed using LC-ESI-MS.  
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Figure 2 Ð Complete product analysis of xanthan oligosaccharides produced from the 
digestion of lyase-treated xanthan by PspXan9. A. HPSEC-UV analysis of products from a time 
course digestion. Limit digest products are observed following 9.5 h of incubation (see Figure S5 
for a full time-course). B. Mass spectrum of the unsaturated octasaccharide product (turquoise) 
found at 32.4 min elution time after a 2 h incubation, and the mass spectrum of acetylated (green) 
and unacetylated (magenta) unsaturated tetrasaccharides found in the partial digest (2 h) and the 
limit digest (9.5 h) and eluting at 33.2 min (see Figure S6 for chromatograms). C. Extracted ion 
chromatograms showing the acetylated (green) and unacetylated (magenta) unsaturated 
tetrasaccharides limit digest products and their subsequent reduced and deacetylated form (blue) 
after treatment with NaBH4. Two chromatographic peaks were observed for each species due to 
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the resolution of reducing-end anomers. D. MS/MS results comparing the unacetylated unsaturated 
tetrasaccharide (magenta) and the NaBH4-reduced derivative (blue), with key ion fragments 
identified above their corresponding masses (see Figure S6-S8 for full MS/MS spectra). E. The 
diagnostic region of the 1H,13C HSQC and HMBC 2D-spectra for the identification of the PspXan9 
products (see Figure S12 for full 2D-heteronuclear NMR spectrum). Each red crosspeak 
corresponds to a 1JC,H-coupling interaction from the HSQC experiment. 2JC,H- or 3JC,H-couplings 
were generated with HMBC experiments optimized for couplings at 5 Hz or 10 Hz, and are 
represented by blue and purple crosspeaks, respectively. The dotted arrows aid in tracing the path 
between the red HSQC crosspeaks of both of the C3-H3 peaks from the α/β-glucose reducing end 
(Glc(r.)) glucose through blue/purple HMBC crosspeaks to the red HSQC crosspeak of the C1-H1 
of mannose. F. Structure of the unsaturated xanthan tetrasaccharide and key 2D-heteronuclear 
interactions illustrating those as seen in panel E. Note, for panels E-F, roman numerals i-iv show 
important correlations and their position within the unsaturated xanthan tetrasaccharide. 
Abbreviations used: r., reducing end; n.r., nonreducing end; Glc, glucose; Man, mannose; Δ4,5-
GlcA; Δ4,5-ene-GlcA. Note, for panels B-D colors correspond to isolated products with turquoise 
being unsaturated xanthan octasaccharides, magenta being unacetylated unsaturated 
tetrasaccharides, green being acetylated unsaturated tetrasaccharides and blue being reduced de-
/un-acetylated unsaturated tetrasaccharides. The notation states the sugar residue and its 
corresponding atom(s) below it. The sugar residue containing the carbon atom is always listed 
first, followed by the residue containing the proton atom. However, if both carbon and proton 
atoms exist within the same residue, the residue is only listed once. 
 
LC-ESI-MS analysis of the 9.5 h sample revealed that the primary limit-digest products were the 
unsaturated tetrasaccharide (661 m/z) and two mono-acetylated derivatives (703 m/z; Figure 2b & 
2c, cf. Figure 1c). Detailed analysis of the 2 h sample likewise indicated the presence of these two 
products (Figure 2b & S6b-c), in addition to masses consistent with non- (1305m/z), mono- (1347 
m/z), and di-acetylated (1389 m/z) octasaccharides corresponding to dimers of the tetrasaccharides 
(Figure 2b & S6f-h). The presence of both tetra- and octasaccharide products indicates that 
PspXan9 is capable of cleaving lyase-treated polytetrameric xanthan (Figure 1) at intervals of 
either two or four backbone glucose residues, and rationalizes the observation of two low-Mw 
peaks in the HPSEC (Figure 2a & S5). In addition to these major products (Figure S6b-c & f-h), 
extracted-ion chromatograms revealed the presence of low levels of monoacetylated, 
depyruvylated pentasaccharide (883 m/z) (Figure S6d), and di-acetylated, depyruvylated 
pentasaccharide (925 m/z) (Figure S6e) resulting from incomplete cleavage of the native 
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polysaccharide by the xanthan lyase (Figure 1), which showed high specificity for pyruvylated 
mannose 17.  
Reduction of the limit-digest products with NaBH4 resulted in the conversion of the non- and 
monoacetylated tetrasaccharides to a single alditol product of 663 m/z (Figure 2c). The location of 
the side chain was indicated by individual MS/MS analysis of the 661 and 663 m/z precursor ions 
of the tetrasaccharide and alditol, respectively (Figure 2d & S7-S8). Diagnostic product ions from 
the reducing-end glucose and glucitol were identified by the corresponding Δ m/z of 2. These 
included Y1 (481 vs. 483 m/z) and Z1 (499 vs. 501 m/z) ions (Figure 2d, see Figure S7-S8 for 
fragment structures). The presence of a B1 ion of 161 m/z and a C1 ion of 179 m/z in both MS/MS 
spectra (and absence of a Y1 ion of 181 m/z and Z1 ion of 163 m/z in the alditol) further suggested 
that the side chain emanated from the reducing-end Glc, as indicated in Figure S7-S8. 
To provide further support for the proposed structure of the unsaturated tetrasaccharide, a series 
of NMR analyses were conducted. A combination of selective 1H 1D-TOCSY, 1H 2D-TOCSY and 
COSY experiments (Figure S9-S11) allowed for a complete proton assignment, including coupling 
constants and multiplicities (Table S1). Identification of the spin systems corresponding to 
individual monosaccharide residues was accomplished by individually irradiating anomeric 
protons between δ 4.29-5.36 ppm (Figure S9a) using selective 1H 1D-TOCSY experiments (Figure 
S9b-g)28-29; the identities of the anomeric protons were inferred from literature values 29 or 
authentic standards (data not shown). Of particular note, the α-mannosyl residue presented two 
anomeric protons as apparent singlets at δ 5.35 and 5.38 ppm (3JH1,H2 < 1 Hz, Table S1). 
Simultaneous irradiation of these peaks was insufficient to reveal the complete α-mannose spin 
system, due to weak equatorial coupling via H2 (Figure S9e). In contrast, irradiation of H2 (δ 4.29 
ppm) revealed all of the Man ring protons (Figure S9f) as well as the two singlets. The appearance 
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of two anomeric signals, and the complexity of the H3-H5 peaks (Figure S9f) is suggestive of 
conformational flexibility of this core mannosyl unit.  
Irradiation of a peak within the anomeric range at δ 4.34 ppm revealed the Δ4,5-ene-GlcA (ÒΔ4,5-
GlcAÓ in Figures 2, S9, S12-S13) spin-system and was later determined to be H3 through 1H 2D-
TOCSY and COSY experiments (Figure S9g & S10-S11). These techniques also allowed the 
assignment of the Δ4,5-ene-GlcA anomeric peak which was buried beneath the HOD peak (δ 4.73 
ppm; Figure S10-S11). Interestingly, the anomeric proton of the β(1→2)-linked Δ4,5-ene-GlcA, 
also appeared as two doublets, further suggesting distinct conformers.  
Most 13C assignments were inferred by matching proton chemical shifts with 1JC,H correlations in 
HSQC experiments (Figure S12; Table S1). However, to determine the carbohydrate sequence and 
the full 13C assignment of Δ4,5-ene-GlcA (due to the lack of 1JC,H present of Δ4,5-ene-GlcA C5 
and C6), HMBC experiments were performed to obtain 2JC,H- and 3JC,H-couplings. This allowed 
information about glycosidic linkages (3JC,H-coupling) and the assignment of Δ4,5-ene-GlcA C5 
and C6 through the presence of 2JC5,H4 and 3JC5,H3 crosspeaks for C5 and 3JC6,H4 crosspeaks for C6 
(Figure S13). 
Information regarding glycosidic bonds was provided by pivotal correlations including the 
linkages between C1 of the non-reducing-end Glc, Glc(n.r), and H4 of the β-anomer of the 
reducing-end Glc,β-Glc(r.), i.e. (3JGlc(n.r.)-C1,β-Glc(r.)-H4), as well as between C3 or H3 of α/β-Glc(r.) 
and the mannosyl anomeric centre (3JMan-C1,α/β-Glc(r.)-H3; 3Jα/β-Glc(r.)-C3,Man-H1) (Figure 2e-f & S12). 
Lastly, position 3 of the Glc(n.r) only has intra-residue HMBC correlations, and thus lacks any 
correlations with chemical shifts matching the mannosyl anomeric centre. This provides strong 
evidence of the absence of a side chain at this position.  
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Together, the MS and NMR data suggest that PspXan9 specifically hydrolyzes the β(1→4)-glucan 
backbone of tetrapolymeric xanthan at the glucosidic bond of the branched glucosyl residues, i.e. 
those appended with β(1→2)-Δ4,5-ene-glucuronyl-α(1→3)-mannosyl side chains (Figure 1). This 
specificity was previously observed for an endo-xanthanase from Bacillus sp. GL1 by sequential 
enzyme degradation9. This specificity is distinct from xanthan-active cellulases (endo-
β(1→4)glucanases), which have been shown to hydrolyze the native polysaccharide at non-
branched Glc residues to produce pentasaccharides30-31. 
 
3-D structure of an endo-xanthanase 
The structure of PspXan9 was solved using single isomorphous replacement with anomalous 
scattering from a K2Pt(SCN)4 derivative and was refined at 2  resolution (Table S2). The structure 
displays a complex six-domain organization as introduced above (Figure 3). The C-terminal 
CBM84 domain is comprised of highly disordered residues (919-1055) and therefore could not be 
traced unambiguously in final structure. For this reason, the residues in the three unconnected β-
strands of the CBM84 domain are described as unknown (UNK) in the final model.  
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Figure 3 Ð Overall organization of PspXan9. (A) Schematic showing the organization of the 
domains from PspXan9 (domains colored as in (B). (B) Ribbon representation of the overall fold 
colored by domain, from the N-terminus: Ig-like, X229 domain (1-90) (blue), GH9 catalytic 
module (91-559) (ice blue), β1 (560-657) (green), β2 (658-814) (yellow), β3 (815-914) (coral), 
CBM84 domain (915-1055) (red). The calcium ions are shown as brown spheres, sodium as grey. 
Bis-Tris-Propane (BTP) indicates the location of the ligand binding site, shown as spheres colored 
by atom. (C) Superimposition of PspXan9 (brown) with 1CLC, the endonuclease D from 
Ruminiclostridium thermocellum. 
 
The first two domains are typical of GH9 enzymes. The most similar structure to the catalytic 
domain is the endo-glucanase CelD from Ruminiclostridium thermocellum (PDB code 1CLC) with 
an r.m.s.d of 2.0  for 464 equivalent Cα atoms (superposed using SSM32 within CCP4mg33, 
(Figure 3c) with which PspXan9 shares around 20% sequence identity. The three all-β domains 
(Figure 3a) are absent from 1CLC. Sequence homology is shared between PspXan9 and the GH9 
protein with accession code BAJ75824.1 [MTES_2860 Microbacterium testaceum StLB037; 43% 
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sequence identity] which has an equivalent region containing all three β domains (residues 561-
918 of MTES_2860), but lacks the C-terminal CBM84 domain (915-1055). Interestingly, apart 
from this there is a single example of two of the β domains found together, at the N-terminus of 
sequence entry ALQ30003.1 (Figure 3a). 
Several electron density peaks have been modelled as metal ions (Figure 3b), with five metals 
annotated as calcium based on geometry and B-factors, and more importantly by small but 
significant peaks in the anomalous difference Fourier. The GH9 family of endoglucanases are 
extracellular enzymes secreted by both bacteria and eukaryota with structures of 16 family 
members currently reported in the CAZY database. Many of these contain one or more calcium 
ions assumed to enhance their stability, while the number of calcium sites varies considerably 
between enzymes. For example, the endoglucanase from R. thermocellum (PDB 1CLC) contains 
three calciums plus a zinc ion, while endoglucanase 9g from Clostridium cellulolyticum (PDB 
1G87) has two calciums, together with three magnesium ions. The positions of the calcium sites 
are not widely conserved across the family. The first Ca2+ ion does correspond to a Ca2+ ion found 
in 1CLC, and is coordinated by the main chain of Ile197 and the side chain oxygens from Asp191, 
Asp193, Asn195, Asp199, and Asp202 that form a calcium binding loop in the GH9 domain. The 
other three metal (two calcium and one zinc) sites from 1CLC are absent in PspXan9. There is a 
possible Ca2+ bound to Glu923 and Glu925 from the CBM84 domain, plus some unidentified 
residues within this domain, but the quality of the electron density in that region is not good enough 
to model these residues with confidence. This is highly significant in light of the HDX-MS analysis 
in the presence and absence of Ca2+ described below.  
The active site is an open cleft typical for endo-acting glucanases34. Comparison with a 
representative GH9 family protein-ligand complex structure (1GA2, endo-glucanase Cel9G from 
 17 
Ruminiclostridium cellulolyticum complexed with cellobiose35, shows the expected close 
similarities in location and conformations of the catalytic residues, as well as a number of other 
ligand binding residues (Figure 4a). The conserved catalytic residues are Glu536, acting as an acid, 
and Asp158 or Asp161 as putative bases in an inverting mechanism. Some residues differ between 
Psp and cellulose-active GH9s, e.g. Glu424 instead of Arg315, which coordinates the ligand in 
1GA2, and Phe420 which replaces Trp311 in the Ð2 subsite (Figure 4a). Unlike 1GA2 and 1KFG 
(a thio-oligosaccharide complex of R. cellulolyticum, Cel9G), the binding cleft of PspXan9 is 
shallower and partly shielded on the outside by the second and third subdomains of the all-β 
domain 3 (Figure 4b. 
 
A
) 
B) 
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Figure 4 Ð The active site. (A) Stereo view of the binding site of PspXan9 superposed on the 
corresponding region of endo-glucanase Cel9G from Ruminiclostridium cellulolyticum (1GA2). 
Residues are shown as cylinders, ligands as ball and stick, and metal ions as spheres. The amino 
acids are colored by atom but with the carbon atoms in ice blue (PspXan9) and gold (1GA2). The 
left-hand number refers to the residue in PspXan9 followed by that for 1GA2. The cellobiose 
ligands are shown in yellow in ball and stick, and the magnesium and BTP are from PspXan9. (B) 
The active site of PspXan9 shown as an electrostatic surface. This was superposed on the 
equivalent region of the tetrasaccharide complex of the Cel9G from R. cellulolyticum (1KFG), 
with the saccharide shown in ball and stick colored by atom, and the surrounding residues in gold. 
The ligand occupies the Ð4 to Ð1 sugar-binding subsites, and the C3 atoms of residues Ð1 and Ð3 
are labelled.  
 
Attempts were made to co-crystallize the enzyme with xanthan tetrasaccharide, but these 
experiments were unfortunately, unsuccessful, so to investigate whether there is space to 
accommodate the larger xanthan ligand in the active site of PspXan9, we superimposed its 
structure with that of the tetrasaccharide complex of the Cel9G from R. cellulolyticum (1KFG), 
(Figure 4b). The site is much more open in PspXan9, and there is considerable space around the 
ligand which should easily be able to accommodate the xanthan side chains. 
 
Conformational Dynamics of PspXan9 Measured by Solution-Phase HDX-MS. 
The conformation and dynamics of PspXan9 in solution were determined by monitoring the 
hydrogen/deuterium exchange of backbone amide groups of a protein by mass spectrometry. In 
PspXan9 the local (peptide level) HDX-MS analysis reports on the conformational dynamics of 
99% of the backbone amide hydrogens that are covered by 267 overlapping peptic peptides (Figure 
S14 & S15). Considering the HDX of PspXan9 over the 1 h time course, it was evident that there 
are major differences in regional deuterium uptake and thus dynamics in the protein (Figure 5). In 
the Ig-like (X229) domain, fast HDX is observed in residues 46-5 (>80% D) and 67-76 (>90% D), 
whereas for the domain GH9, residues 187-190 (100% D), 274-291 (>80% D), 309-332, (>80% 
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D) and 416-420 (100% D) show fast HDX. Region 187-190 is in close proximity to the calcium 
ion, coordinated by Asp191, Asp193, Asp195, Asp199 and Asp202.  
 
Figure 5 - Solution-phase conformational dynamics of PspXan9. The relative deuterium 
content of PspXan9 at the labeling time intervals 15 s, 30 s, 1 min, 10 min and 1 h was adjusted to 
the fully deuterated control and mapped on the X-ray crystal structure according to the indicated 
color scale. Regions without HDX information are shown in grey. The calcium and platinum ions 
are shown in magenta and green spheres, respectively.  
 
 
At shorter time points, for example 15 s, the loop connecting GH9 domain and β1 (res. 554-566) 
show more than 50% deuterium uptake increasing to more than 90% after 1 h. Notably, the position 
of S560 is not visible in the crystal structure reflecting this intrinsic flexibility. The loop (res. 588-
600) in the β1 domain also show a similar pattern in going from more than 50% to 90% over the 
HDX time course with deuterium uptake extending to residues 588-611.  
Domain β3 and parts of the nearby β2 show some of the most pronounced dynamics. At the earliest 
sampling time point of 15 s, residues 811-822 and 869-883 of β3 show more than 50% deuterium 
uptake. After 1 h HDX this deuterium uptake increases to over 80% and has propagated to nearby 
regions 845-856 and 898-906 in β3 and region 775-782 in β2. The loop 764-782 show more than 
80% deuterium incorporation after only 15 s indicating highly dynamics nature and solvation. In 
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the CBM84 domain (Table S3), which is significantly disordered in our crystal structure, the 
largest deuterium uptake after 1 h was observed for residues 965-972 (90%), 991-1012 (>80%), 
1013 (>70%), 964 (>70%). These, as well as residues 1015-1026 all show deuterium uptake over 
50% after 15 s HDX, indicating significant solvation and a highly dynamic nature; consistent with 
the crystal structure observation.  
Impact on Conformational Dynamics of Calcium Ion Removal by EDTA Chelation. 
As described above, the stability of PspXan9 is dependent on the presence of calcium ions. To 
understand further the role of calcium on the conformation and dynamics of PspXan9, we 
measured the HDX of PspXan9 in the presence of the divalent cation chelator EDTA (Figure 6, 
Figure 7 and Table S4). 
 
Figure 6 - Solution-phase conformational dynamics of PspXan9 in the presence of 10 mM 
EDTA. The relative deuterium content of PspXan9 in the presence of 10 mM EDTA at the labeling 
time intervals 15 s, 30 s, 1 min, 10 min and 1 h was adjusted to the fully deuterated control and 
mapped on the X-ray crystal structure according to the indicated color scale. 
 
Backbone amide hydrogens in the vicinity of all sites shown in the X-ray structure of PspXan9 to 
coordinate calcium ions were impacted by EDTA treatment. The two calcium binding loops in the 
GH9 domain show minor, but statistically significant, increases in deuterium uptake at the 1 h time 
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point with region 192-200 and 228-251 showing a 2.5% and 5% increase, respectively. In the 
structured calcium binding site in the interface between GH9 and the β1 domain the region 640-
647 containing Tyr641 and Ser642 show an increase in deuterium uptake from 2.5% to 15% during 
1 h HDX. Thus, Ca2+ has a local stabilizing effect on the conformation of PspXan9 in these regions. 
In contrast, the region 406-414 covering the calcium binding residues Asp407 and Glu408 shows 
decrease in deuterium uptake of 2.5% after 10 min and 1 h labelling. Interestingly, residues 567-
570 in the nearby loop show the largest decrease in deuterium uptake of 7.5% when PspXan9 is 
treated with EDTA. Local decreases in HDX in the presence of EDTA indicates that Ca2+-
coordination in these regions constrains several backbone hydrogens in an exposed exchange-
competent conformation, which in turn collapses into a more protected conformation in the 
absence of the divalent cation.  
 
Figure 7 - Impact of calcium ion removal on the conformational dynamics of PspXan9. 
Differential deuterium uptake in PspXan9 in the native state and in the presence of 10 mM EDTA. 
Residues with a positive relative differential deuterium uptake have increased HDX in the presence 
of EDTA in comparison to native PspXan9 and vice versa for a negative relative differential 
deuterium uptake. Regions without HDX information are shown in dark grey. 
 
Surprisingly, domain β3 showed the largest, earliest and most widespread effects upon calcium 
ion removal. Region 869-833 shows the highest differential increase in deuterium uptake in the 
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Ca2+ depleted state after 15 s of HDX, with an increase of 10%, which in turn decreases to 5% 
after 1 h. Residues 841-844, 845-856 and 897-906 all showed a differential increase in deuterium 
uptake starting at 5% at the first time point and ending above 20%, 25% and 55%, respectively at 
the final 1 h time point. No calcium ions could be assigned in this area of the crystal structure. 
However, inspection of the sequence of the perturbed regions, reveals the presence of Asp901 and 
Asp846 (which is located in a loop in close proximity, 845-856) which bind a metal-ion currently 
modelled as Na+ (on the basis of weak density) which we predict is likely to be a Ca2+ binding 
region.  
In the CBM84 domain, there are several regions where backbone amide hydrogens undergo 
correlated exchange kinetics (EX1 kinetics) in the presence of EDTA indicated by characteristic 
bimodal isotopic distributions (Figure 8). The occurrence of both a protected and a fully exchanged 
population reveals that some backbone amide hydrogens in these regions have rates of closing (kcl) 
much lower than the chemical exchange rate (kch). Thus, the slow refolding rate of these regions 
leads to complete deuteration of the backbone amide hydrogens upon one unfolding event and thus 
reports directly on the rate of opening (kop) of the affected residues. This is in contrast to the 
exchange kinetics observed in all other regions in PspXan9 where the kcl is much higher than kch 
and thus several opening events take place before the backbone amide hydrogens are completely 
deuterated (EX2 kinetics). The correlated unfolding dynamics of the three regions all occur with 
relatively slow rates (kop) with half-lives of the slow-exchanging protected population between 10 
min and 1 h. Furthermore, about 14-15 backbone amide hydrogens in peptide 928-959, 9 in 973-
989 and 11-12 in 1028-1048 can be seen to be involved in the correlated and slow 
unfolding/refolding dynamics. The slow correlated unfolding kinetics seen for residues of region 
973-989 can be narrowed down to residues 980-989 as the overlapping peptide 973-979 only show 
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unimodal exchange kinetics (EX2), correlating well with the measured number of amides showing 
EX1 kinetics. 
Figure 8 - Slow and correlated unfolding dynamics of the C-terminal CBM84 domain 
ofPspXan9 in the absence of Ca2+. MS spectra of PspXan9 in the presence and absence of 10 mM 
EDTA at the time interval from 0 min to 1 h for peptide A) 928-959 (MH5+), B) 973-989 
(MH3+)and C) 1028-1048 (MH3+). The raw data were fitted to a binominal isotopic distribution 
(population1: blue curves, population 2: red curves). 
 
The pronounced impact of Ca2+ removal on this domain strongly suggests that there is indeed at 
least one calcium binding site in the CBM84 domain. The X-ray structure, supported by a weak 
but significant anomalous scattering signal, indicated the presence of at least one Ca2+ site in the 
CBM84 domain, coordinated by side chain oxygens of what we believe are Glu923 and Glu925 
and Asp1047.  
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Generation of Stable PspXan9 Variants in the Absence of Calcium Ions 
The xanthan degrading properties of this class of enzyme leads to potential applications in cleaning 
detergents. However, to increase washing performance, detergents typically contain chelators to 
bind divalent cations from the washing water and lower the water hardness. Therefore, we sought 
to generate PspXan9 variants with high stability and activity in the absence of calcium ions. To do 
this, several variants were generated based on selecting positions shown as either having high 
mobility in the HDX-MS data, or being predicted to lie adjacent to those regions on the basis of 
modelling. At each position, saturation mutagenesis was performed. The activity and stability of 
the variants were evaluated by measuring residual activity and half-life improvement factors (HIF) 
(Table 2). 
Table 2. Variants with improved stability after incubation in liquid detergent 
Variant/ 
Mutation 
Residual activity 
(%) 
HIF 
N966C 39 (3) 1.24 (0.06) 
K1031I 39 (1) 1.23 (0.04) 
S636M 37 (3) 1.17 (0.15) 
K627Q 37 (2) 1.19 (0.07) 
A559H 45 (5) 1.43 (0.08) 
Wild type 32 (2.6) 1.00 (0.04) 
Numbers in parentheses indicate standard deviations. 
 
Variants were incubated in a liquid model detergent (Table S5) (70% detergent concentration) at 
either 4 or 30 ¡C for 22 h. After incubation, the enzyme activity on xanthan-lyase treated xanthan 
gum was determined, and residual activities were calculated as Act30¡C/Act4¡C x 100%. Based on 
the residual activities after incubation at 30 ¡C, half-life (T1/2) and half-life improvement factors 
(T1/2variant/T1/2native enz) were calculated (Table 2). 
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Comparative HDX-MS analysis of Ca2+-bound and Ca2+-depleted PspXan9 showed that regions 
most impacted by Ca2+ depletion were the β3 domain and the CBM84 domain as they encompass 
the peptides displaying the higher deuterium uptake differences upon Ca2+ removal (Table S4). 
Other, less pronounced effects were observed in the GH9 catalytic domain (for example regions 
95-105, 227-251 and 291-296) (Table S4). Finally, several inter domain loops showed increased 
deuterium uptake upon Ca2+ depletion: segments 551-569 (connecting the GH9 and β1 domains), 
639-660 (connecting the β1and β2 domains) and 809-822 (connecting the β2 and β3 domains) 
(Table S4).  
Saturation mutagenesis (not shown) at two positions of the CBM84 domain yielded variants 
N966C and K1031I which showed high half-life improvement factors (HIF 1.24 and HIF 1.23) 
highlighting the benefit of targeting mobile regions in the comparative HDX-MS K1031I seems 
to be adjacent to all dynamic segments while N966C is adjacent to segments 928-959 and 980-989 
that are closest to the mutation site in sequence and within the structure.  
Similarly, S636M and K627Q are both located in the β1 domain, which also has a conformation 
that is closely tied to a coordinating Ca2+ ion. On top of this, both mutations neighbor region 639-
660, which showed increased deuterium uptake upon Ca2+ removal (Table S4). The activity 
stabilizing effect of S636M and K627Q (HIF 1.17 and HIF 1.19) is therefore presumably linked 
to the stabilization of this Ca2+-dependent region in the β1 domain.  
The A559H mutation displayed the highest stabilizing effect (HIF 1.43). A559H is also located in 
the β1 domain; however, unlike S636M and K627Q, the A559H mutation is in a loop connecting 
the β1 and the GH9 domains. Thus, this mutation is much further from the 639-660 region and the 
Ca2+ ion than S636M and K627Q. The peptide segment encompassing A559H displays fast 
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deuterium uptake (residues 554-566, up to 50% at 15 s and 90% at 1 h) indicating considerable 
dynamics and flexibility of this loop region. By successfully increasing the stability of this inter-
domain loop, A559H may thereby have enhanced the overall stability of the enzyme. Furthermore, 
residues 554-566 display a slight increase in deuterium uptake upon Ca2+ removal at the 10 min 
time point (Table S4) suggesting that this loop region is linked to the Ca2+ binding site despite the 
mutation site being further from it. In the structure, the loop is tethered close to the region 
coordinating the Ca2+ ion and thus by stabilizing the loop the mutation appears to have indirectly 
stabilized the Ca2+ binding site. 
CONCLUSIONS 
The increasing application of diverse polysaccharides in industrial and societal processes demands 
improved knowledge of the biological catalysts that synthesize, modify and degrade these 
polysaccharides. The polysaccharide xanthan is a prime example. Its gel-like properties mean that 
it finds astonishingly diverse application, not only in food production but also in pharmaceutical 
formulation and petroleum extraction. There is therefore a need to find catalysts capable of 
degrading this unusual polysaccharide. Here we have reported the identification of and defining 3-
D structure for a new class of xanthan degrading enzyme Ð hydrolytic endo-xanthanases. We have 
shown that the enzyme has an unusual, multi-domain, 3-D structure with an open active center 
cleft that is able to bind and degrade polymeric xanthan in a processive manner. Industrial 
application xanthanases, indeed most glycoside hydrolases, often requires unusual conditions, 
placing additional stability demands on the catalyst. Here we have demonstrated the power of the 
H/D exchange method to identify regions of high mobility in both the presence and absence of 
Ca2+, as well as to inform rational protein engineering approaches to enzyme stability which led 
to catalysts with improved half-lives in relevant conditions. The Paenibacillus GH9 endo-
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processive xanthanase thus provides not only a first insight into natureÕs hydrolytic pathway for 
xanthan degradation but provides a blueprint for the rational redesign of enzymes, one of a number 
of tools that now allow the improvement of enzymes for societal benefit. 
 
 
 
EXPERIMENTAL 
Cloning, Expression and Purification 
The PspXan9 gene was inserted into a Bacillus expression plasmid, essentially as described for a 
phospholipase 36 with an affinity tag sequence to easy the purification process. Briefly, the DNA 
encoding the mature polypeptide predicted by Signal P 37  was cloned in frame to the Bacillus 
clausii secretion signal, BcSP, replacing the native secretion signal sequence followed by a 
polyhistidine tag (HHHHHHPR). This resulted in a recombinant mature polypeptide with the His-
tag (HHHHHHPR) in front of the N-terminus of the mature wild type sequence. A recombinant B. 
subtilis clone containing the integrated expression construct was selected and cultivated on a rotary 
shaking table in ten 500 mL baffled Erlenmeyer flasks each containing 100 mL LB media 
supplemented with 34 mg!L-1 chloramphenicol. The clone was cultivated for 5 days at 30 ¡C. The 
enzyme-containing supernatants were separated from the cells by centrifuging the culture broth 
for 30 min at 15.000 × g and the enzyme was purified as described below. 
The decanted supernatant was mixed with ammonium sulfate and Tris-HCl, pH 7.5 to obtain a 
final ammonium sulfate concentration of 800 mM in 20 mM Tris-HCl, pH 7.5. The sample was 
incubated for 30 min at room temperature with continuous stirring. Precipitate and bacterial cells 
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were removed by passing the sample through a 0.2 µm Nalgene filtration system. Column 
chromatography was done by using an AKTA Explorer FPLC (GE Healthcare). The filtered 
sample was loaded on a 50 mL Phenyl Sepharose High Performance column (GE Healthcare, 
Uppsala, Sweden) equilibrated in 20 mM Tris-HCl, pH 7.5, 800 mM ammonium sulfate. Proteins 
were eluted by step elution with 20 mM Tris-HCl, pH 7.5. Eluted fractions were analyzed using 
SDS-PAGE and fractions eluting at 280 mM ammonium sulfate were pooled. The pool was applied 
on a 20 mL HisPrep fast flow column (GE Healthcare) equilibrated with 500 mM NaCl, 20 mM 
Tris-HCl, pH 8.5. Proteins were eluted by a linear gradient using 500 mM NaCl, 500 mM 
imidazole, 20 mM Tris-HCl, pH 7.5. Eluted fractions were analyzed by SDS-PAGE. Fractions 
with increased purity were pooled and buffer exchanged to 20 mM Tris-HCl, pH 8.5 by using a 
340 mL G25 superfine desalting column. The desalted sample was applied on a 20 mM Source 
15Q column equilibrated in 20 mM Tris-HCl, pH 8.5. Elution was done by a linear gradient from 
0.0 to 200 mM NaCl in the same buffer over 4 column volumes. The purity of the eluted fractions 
was evaluated using SDS-PAGE and fractions judged as > 95% pure were pooled and buffer 
exchanged to 20 mM Tris-HCl, pH 8.5. The intact protein mass of these samples was determined 
to be 115972 Da using a nanoACQUITY UPLC/Xevo Q-TOF MS system, essentially according 
to methods previously described 38 (Figure S16). Protein concentration was calculated from A280 
values using the theoretical extinction coefficient of 199860 M-1cm-1 based on the deduced mature 
amino acid sequence. 
 
Site-directed variants of mature PspXan9 were engineered by the megaprimer mutagenesis method 
using specifically designed mutagenic oligonucleotides introducing desired mutations in the 
resulting sequence. Consequently, mutagenic oligonucleotides were designed and synthesized 
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corresponding to the DNA sequence flanking the desired site(s) of mutation, separated by the DNA 
base pairs defining the substitutions. The final expression cassette composed the PspXan9 gene as 
described above. Successful introduction of the desired substitutions was confirmed by DNA 
sequencing of the PspXan9 variant gene. An aliquot of the PCR product was subsequently 
transformed into Bacillus subtilis. Transformants were selected on LB agar plates supplemented 
with 10 mM K2PO4, 0.4% extra glucose and 6 µg!mL-1 of chloramphenicol. The resulting 
recombinant Bacillus subtilis clones containing the integrated expression construct were grown in 
liquid TB-glycerol medium containing a standard trace metal mix39 for 4 days at 30¡C before 
harvested and purified as for the mature PspXan9 described above. 
Carbohydrate Sources 
Xanthan gum (item no. XA105), referred to herein as Ònative, polypentameric xanthanÓ (Figure 
1), was purchased from Spectrum Chemical, New Brunswick, NJ, USA. Barley mixed-linkage 
glucan (bMLG), tamarind seed xyloglucan (tXyG), beechwood xylan (bGX) and wheat-flour 
arabinoxylan (wAX) were purchased from Megazyme (Bray, Ireland). Carboxymethylcellulose 
(CMC) was purchased from Acros Organics (Morris Plains, NJ, USA). Hydroxyethylcellulose 
(HEC) was purchased from Amresco (Solon, OH, USA). ÒLyase-treated xanthanÓ (Figure 1) was 
prepared by xanthan lyase treatment of native, polypentameric xanthan essentially according to a 
method described previously9. Briefly, xanthan gum was dissolved in 50 mM HEPES-NaOH 
buffer, pH 7.0, to a concentration of 2.5 g!L-1 and treated with 0.5 U!mL-1 of Bacillus sp. xanthan 
lyase (EC 4.2.2.12, CAZy Family PL8, Megazyme cat. no. E-XANLB). The formation of Δ4,5-
ene-glucuronyl residues was monitored using a Cary 60 UV-visible spectrometer with a 1-cm path 
length quartz cuvette at an absorbance of 235 nm 6. Once the A235 value reached a plateau, an 
additional 0.5 U࣭!mL-1 of xanthan lyase was added and the reaction was monitored to ensure 
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completeness. Lyase-treated xanthan was purified by precipitation essentially as previously 
described6, 9, except ice cold 2-propanol was used instead of ethanol, and the mixture was 
centrifuged at 4500 × g for 20 min to aid in supernatant removal. The precipitated lyase-treated 
xanthan was placed in a vacuum desiccator for 72 h to remove residual 2-propanol prior to 
dissolution in ultrapure H2O for enzyme assays. 
 
Enzyme Kinetic Analysis 
Enzyme kinetics on soluble polysaccharides were determined by quantifying the generation of new 
reducing chains ends using a copper/2,2'-bicinchoninic acid (BCA) assay in an optimized, low 
volume format40. D-Glucose standard curves were measured between 0 and 125 µmol in 50 mM 
HEPES-NaOH, pH 7, with or without 2 mM CaCl2, as appropriate. To reduce the nonspecific 
absorption of enzyme on vessel surfaces, suitably diluted PspXan9 was premixed with 0.1 mg!mL-
1 bovine serum albumin (BSA) in 5 mM HEPES-NaOH buffer, pH 7, unless otherwise specified; 
this solution was ultimately diluted 10-fold into the assay solution. In general, assays were initiated 
by the addition of enzyme after preheating substrate in buffer to the desired temperature for at least 
15 min. Reactions were terminated by the addition of ice cold BCA reagent at a 1:1 v/v ratio and 
concentrations of the Cu+-BCA complex were determined from A562 measurements. 
 
All reactions to optimize activity were conducted using 0.5 mg!mL-1 of lyase-treated xanthan based 
on preliminary results24. The effect of calcium ions on activity was determined by incubating 1.59 
nM PspXan9 with lyase-treated xanthan at 37 ¡C in 50 mM HEPES-NaOH buffer, pH 7.0, 
containing 0-10 mM CaCl2. The optimal temperature for activity was determined by incubating a 
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final enzyme concentration of 0.8 nM with lyase-treated xanthan in the 50 mM HEPES-NaOH 
buffer, pH 7.0, between 30 ¡C and 78 ¡C. The pH rate profile was characterized by incubating 0.8 
nM of enzyme with lyase-treated xanthan at 55 ¡C in selected buffers (50 mM) between pH 3.6-
10.6. The buffer and pH range used were as follows: sodium acetate, pH 3.6-5.5; MES, pH 5.38-
7.0; HEPES-NaOH, pH 7.0-8.5; CHES, pH 8.5-10.6. 
The effect of Ca2+ ions on thermostability of PspXan9 maintained at temperatures between 45 ¡C 
and 69¡C (Bio-Rad Thermal Cycler S1000) was determined by incubating 16 nM of the enzyme 
in the presence or absence of 20 mM CaCl2 and measuring remaining hydrolytic activity toward 
0.5 mg!mL-1 lyase-treated xanthan over time. The conditions of the BCA assay were adjusted to 
ensure that all assay solutions contained a final concentration of 2 mM CaCl2 following the 
addition of enzyme to initiate the reaction (1:10 dilution of PspXan9 in assay). 
Enzyme specific activity was determined for selected substrates by incubating 2 mg!mL-1 native 
polypentameric xanthan, lyase-treated xanthan, bMLG, tXyG, bGX, wAX, bMLG, CMC, or HEC 
with PspXan9 at 55 ¡C in 50 mM HEPES-NaOH buffer, pH 7.0. The PspXan9 concentration in 
the assay was 0.4 nM for lyase-treated xanthan, 191 nM for polypentameric xanthan and CMC, 
and 383 nM for all other polysaccharides. One unit of activity (U) is defined as the amount of 
enzyme required to release 1 µmol of glucose-equivalent reducing ends per minute. Controls 
containing heat-inactivated (incubation at 90 ¡C for 20 min) PspXan9 were used to account for 
high background absorbance resulting from high protein concentration in some samples. Apparent 
Michaelis-Menten kinetic parameters were determined for lyase-treated xanthan by treating 
reaction mixtures at 55 ¡C containing substrate concentrations between 0.01-2 mg!mL-1 lyase-
treated xanthan with 0.4 nM of enzyme. Data were fit with the Michaelis-Menten equation using 
OriginPro software (OriginLab). 
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Enzyme Product Analysis 
Partial hydrolysis products were obtained by incubation at 55 ¡C of 16 nM PspXan9 and 2 mg!mL-
1 lyase-treated xanthan in 50 mM HEPES-NaOH, pH 7, containing 2 mM CaCl2. Following heat 
inactivation, samples were analyzed by HPSEC-UV on an ICS-5000 DC HPLC system operated 
using Chromeleon software version 7 (ThermoFisher). Samples were eluted through a 
UltrahydrogelTM 6 x 40 mm Guard Column in series with a UltrahydrogelTM Linear 7.8 x 300 
mm column using 0.5 M NaCl at 0.6 mL!min-1 for 45 min. Elution was monitored by absorbance 
at 235 nm. 
Mass spectrometric analysis of the partial hydrolysis products following 2 h of reaction incubation 
was performed using a nanoACQUITY UPLC coupled to a Xevo G2-S QTof (Waters Co., Milford, 
MA, USA). Oligosaccharide separation was achieved using a Hypercarb Kappa 3 µm porous 
graphitized carbon column (150 x 0.32 mm). Eluent A comprised 95% 25 mM ammonium formate, 
pH 5, and 5% acetonitrile; eluent B comprised 5% 0.5 M ammonium formate, pH 5, and 95% 
acetonitrile. Samples were eluted at a flow rate of 8 µL!min-1 with the following gradient: 0-5 min: 
95% eluent A and 5% eluent B; 5-25 min: linear gradient to 70% eluent A and 30% eluent B; 25-
25.1 min: linear gradient to 95 % eluent A and 5% eluent B; 25.1-45 min: 95% eluent A and 5% 
eluent B. Mass spectra were collected in negative-ion mode, with a 2 s integration time. Collision 
induced dissociation of the target masses of 661 m/z and 703 m/z were performed using a collision 
energy of 15 eV. To determine the relative position of the branch in PspXan9 xanthanase products, 
the hydrolysis reaction was allowed to go to completion and the limit-digest products were diluted 
to 1 mg!mL-1 with 50 mM sodium carbonate buffer, giving a final pH of 10. NaBH4 (S678-25, 
Fisher Scientific) was added to a final concentration of 1 M and incubated at room temperature for 
12 h before the quenching by the addition of 1 M acetic acid to give a slightly acidic pH (5-6). The 
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reduced oligosaccharides were analyzed by mass spectrometry using the same method as described 
above, only the final isocratic gradient was reduced to 25.1-30 min and collision energy was set to 
25 eV with a target mass of 663 m/z. 
 
Unsaturated xanthan tetrasaccharides were prepared for NMR by performing a limit digest on 12.5 
mg!mL-1 lyase-treated xanthan using 38 nM of PspXan9 with 2 mM CaCl2 in 5 mM HEPES-NaOH 
buffer pH 7.0. Full product conversion was confirmed using HPSEC-UV before the pH was then 
raised to 10 using 28-30% NH4OH (1336-21-6, Fisher Scientific) to deacetylate the sample. The 
deacetylated sample was lyophilized and resuspended in H2O before being desalted into ultra-pure 
H2O using a 100 x 2.6 cm Bio-Gel P-2 column at a flow rate of 0.5 mL!min-1. Fractions absorbing 
at 235 nm were pooled and lyophilized. The sample was resuspended in 500 µL of 99.9% D2O and 
lyophilized, twice. Finally, 3.5 mg of the unsaturated xanthan tetrasaccharide was dissolved in 500 
µL of D2O. NMR experiments were performed using a Bruker Avance 600 equipped with a z-
gradient TCI cryoprobe, with a 1H resonance at 600.15 MHz and a 13C resonance of 150.92 MHz. 
A 1D-1H NMR spectrum and selective 1H 1D-TOCSY NMR spectra with irradiation at 4.29, 4.44, 
4.64, 5.20 and 5.36 ppm followed by 0.12 ms of mixing time were collected. 2D-1H TOCSY, 
COSY and 1H,13C HSQC spectra were collected, as well as 1H,13C HMBC experiments which 
were optimized for coupling at 5 and 10 Hz. All 1H experiments were referenced to the HOD peak 
(δ 4.70 ppm) and all 13C experiments were referenced to external methanol in D2O (δ 49.00 ppm). 
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Crystallization and Data Collection 
Initial crystallization screening was carried out at room temperature using sitting-drop vapor 
diffusion set up using a Mosquito Crystal liquid handling robot (TTP LabTech, UK) with 150 nL 
protein solution plus 150 nL reservoir solution in 96-well format plates (MRC 2-well 
crystallization microplate, Swissci, Switzerland) equilibrated against 54 µL reservoir solution, 
with a number of commercial screens. Initial crystals were obtained in PACT condition E12: 20% 
PEG3350, 0.2 M sodium malonate. Native data were collected at Diamond I04-1 to 2.04  
resolution and processed by xia241 space group P3221, with one molecule in the asymmetric unit. 
Crystallization conditions were manually optimized to produce crystals for heavy atom soaks, with 
final conditions 20-22% PEG3350 and 0.1 M Bis-Tris propane pH 6.5. The crystals were 
transferred to conditions similar to those in which they were grown, but with 2-5% increased 
PEG3350 concentration, and 2-5 mM heavy atom compounds. Several potential derivatives were 
screened; the one that proved successful was K2Pt(SCN)4. Derivative data were collected at 
Diamond, beamline I03, to 2.0  resolution, and were in the same space group as the native with 
closely similar cell dimensions. 
Structure Solution and Refinement 
All computations were carried out using programs from the CCP4 suite42, unless otherwise stated. 
The structure was solved by single wavelength anomalous diffraction method (SAD) using the 
Crank pipeline43, with AFRO/CRUNCH2 44 for substructure detection, BP3 45-46for substructure 
refinement, SOLOMON 47 for hand determination and density modification and BUCCANEER 48 
for model building. The model for the derivative was further refined with REFMAC5 49 iterated 
with manual model building with COOT50. The native structure was refined using the derivative 
structure as a starting model. TLS was used in the refinement for both structures51, with the domain 
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allocation shown in Figure 3a. Both structures were validated using PROCHECK 52 and 
MOLPROBITY53, and the processing and refinement statistics are given in Table S2. 
 
H/D Exchange Mass Spectrometry 
Continuous amide H/D exchange of PspXan9 at a concentration of 1 µM and 22 ¡C was initiated 
by addition of 99.9% deuterated 20 mM Tris, 1 mM CaCl2, pH 8 in the absence or presence of 10 
mM EDTA to a final deuterium concentration of 95%. All H/D exchange reactions were performed 
in triplicate. At five time points ranging from 15 s to 1 h, aliquot samples of the exchange reaction 
were quenched by addition of 1:1 (v/v) ice-cold 6 M guanidinium hydrochloride, 300 mM 
phosphate, pH 2.05 for a final pH of 2.6. The quenched samples were frozen immediately and 
stored at −80 ¡C until LC-MS analysis. Non-deuterated samples were prepared following the same 
procedure but using protiated buffers. Equilibrium deuterated samples (95% D2O) were prepared 
by over-night incubation in 99.9% deuterated 6 M guanidinium hydrochloride and quenched in 
300 mM phosphate, pH 2.3 for a final pH of 2.6. The quenched samples were loaded into a cooled 
HDX-UPLC system (Waters, Milford, USA) for online pepsin digestion using an immobilized 
pepsin column (Pierce, Rockford, USA). The peptides were desalted using a trap column (Waters 
VanGuard C18, 1.7 µM, 2.1 x 5 mm) at a flow of 200µl/min 0.23% formic acid for 3 min and 
peptides were separated by reverse phase chromatography (Waters Acquity BEH C18, 1.7 µm, 1 
x 100 mm) using a two-step gradient from 8-18% in 2 min and 18-40% in 10 min 0.23% formic 
acid in acetonitrile at a flow of 40 µl!min-1. Positive electrospray ionization mass spectrometry 
with ion mobility was performed on the peptides using a Synapt G2 mass spectrometer (Waters, 
Milford, USA). 
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The peptic peptides of PspXan9 were identified by tandem mass spectrometry of non-deuterated 
samples using a combination of data independent (DIA/MSe) and data dependent acquisition 
schemes (DDA) and data-analysis in Protein Lynx Global Server v. 2.5. Deuterium uptake of 
individual peptides was determined using DynamX v. 3.0 (Waters, Milford, USA) or in 
HXexpress54. Statistical analysis (F-tests and student T-tests) were employed to determine 
statistically significant changes in H/D exchange between the analyzed protein states. 
 
Detergent Stability 
To assess the detergent stability of PspXan9 and variants, 0.1 mg!mL-1 purified protein was 
incubated with liquid detergent (see Table S5, 70% detergent concentration) at either 4 ¡C or 30 
¡C for 22 h. After incubation, samples from 4 respective 30 ¡C incubation were transferred into 
96-well plates and further diluted 50 times with dilution buffer (50 mM MOPS, 5 mM CaCl2, pH 
7.5). Reaction mixtures were prepared in 96-well PCR plates by mixing 50 µL of 50 times diluted 
protein samples with 50 µL of freshly prepared lyase-treated polytetrameric xanthan solution 
(0.4% in MilliQ water) and incubated at 48 ¡C for 1 h. After incubation, 75 µL of PAHBAH 
reagent (15 mg!mL-1 4-hydroxybenzoic acid hydrazide (PAHBAH), 50 mg!min-1 potassium 
sodium tartrate tetrahydrate, 20 mg!mL-1 NaOH) was added to each reaction mixture in the same 
PCR plate and incubated further in a programmable thermal cycler for 10 min at 95 ¡C followed 
by cooling at 10 ¡C. 40 µL of each reaction mixture was transferred to a 384-well microtiter plate 
and the absorbance was measured at 405 nm using a spectrophotometer. The residual enzyme 
activity was calculated as Act30¡C/Act4¡C x 100%. Based on the residual activities after incubation 
at 30 ¡C, half-lives (T1/2) and half-life improvement factors (T1/2variant/T1/2native enz) were calculated 
(Table 2). 
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